RANDOX AMIKACIN— 510(k) K033884

Substantially Equivalent

Randox Laboratories, Ltd.

FDA 510(k) clearance K033884 for RANDOX AMIKACIN, Substantially Equivalent on 2004-06-09. Applicant: Randox Laboratories, Ltd..

Clearance details

Applicant: Randox Laboratories, Ltd.
Product code: Code KLQ
Advisory panel: Clinical Toxicology
Date received: 2003-12-15
Decision date: 2004-06-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crumlin, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.